|
|
|
Volumn 21, Issue 10, 2008, Pages 52-65
|
|
Biopharmaceuticals: Approval trends in 2007
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ABSEAMED;
BINOCRIT;
ECULIZUMAB;
EPOETIN ALFA HEXAL;
HUMAN GROWTH HORMONE;
IDURONATE 2 SULFATASE;
MIRCERA;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PANITUMUMAB;
PERGOVERIS;
RANIBIZUMAB;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT HORMONE;
RECOMBINANT SOMATOMEDIN C;
RETACRIT;
SILAPO;
UNCLASSIFIED DRUG;
WART VIRUS VACCINE;
ANEMIA;
ARTICLE;
BACULOVIRUS EXPRESSION SYSTEM;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
EUROPEAN UNION;
GROWTH DISORDER;
GROWTH HORMONE DEFICIENCY;
HORMONE DEFICIENCY;
HUMAN;
HUNTER SYNDROME;
HYPERTENSION;
INJECTION SITE REACTION;
MENINGOCOCCOSIS;
MYALGIA;
NONHUMAN;
OVARY CYST;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
RETINA MACULA AGE RELATED DEGENERATION;
RHEUMATOID ARTHRITIS;
RHINOPHARYNGITIS;
TREATMENT DURATION;
TREND STUDY;
UNITED STATES;
URINARY TRACT INFECTION;
UTERINE CERVIX CANCER;
|
|
EID: 56249114151
PISSN: 1542166X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (6)
|
